These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11150645)

  • 1. New conformationally restricted analog of the immunosuppressory mini-domain of HLA-DQ and its biological properties.
    Szewczuk Z; Wilczyński A; Dyba M; Petry I; Siemion IZ; Wieczorek Z
    Peptides; 2000 Dec; 21(12):1849-58. PubMed ID: 11150645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressory activity of the cyclodimeric peptide with RGD-sequences.
    Szewczuk Z; Buczek P; Stefanowicz P; Krajewski K; Wieczorek Z; Siemion IZ
    Acta Biochim Pol; 2001; 48(1):121-30. PubMed ID: 11440161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further investigations on thymopentin-like fragments of HLA-DQ and their analogs.
    Szewczuk Z; Wieczorek Z; Stefanowicz P; Wilczyński A; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1997; 45(4):335-41. PubMed ID: 9523010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Threonine at position 6 is not essential for the immunosuppressive activity of HLA-DQ(beta164-172)-hexapeptide.
    Stefanowicz P; Boratyński PJ; Staszewska A; Wilczyński A; Zimecki M; Szewczuk Z
    Mol Immunol; 2004 Jul; 41(9):911-7. PubMed ID: 15261463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of a new bridged immunosuppressor.
    Szewczuk Z; Wilczyński A; Petry I; Siemion IZ; Wieczorek Z
    Acta Biochim Pol; 2001; 48(4):1147-50. PubMed ID: 11995982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological properties of the thymopentin-like fragments of HLA-DQ.
    Szewczuk Z; Siemion IZ; Wieczorek Z
    Mol Immunol; 1996 Aug; 33(11-12):903-8. PubMed ID: 8960113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressory mini-regions of HLA-DP and HLA-DR.
    Szewczuk Z; Wilczyński A; Stefanowicz P; Fedorowicz W; Siemion IZ; Wieczorek Z
    Mol Immunol; 1999 Jun; 36(8):525-33. PubMed ID: 10475607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressory activity of ubiquitin fragments containing retro-RGD sequence.
    Szewczuk Z; Stefanowicz P; Wilczyński A; Staszewska A; Siemion IZ; Zimecki M; Wieczorek Z
    Biopolymers; 2004 Aug; 74(5):352-62. PubMed ID: 15222015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary and tertiary structure of the principal human adenylate kinase.
    Von Zabern I; Wittmann-Liebold B; Untucht-Grau R; Schirmer RH; Pai EF
    Eur J Biochem; 1976 Sep; 68(1):281-90. PubMed ID: 183954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimerization of the immunosuppressive peptide fragment of HLA-DR molecule enhances its potency.
    Szewczuk Z; Biernat M; Dyba M; Zimecki M
    Peptides; 2004 Feb; 25(2):207-15. PubMed ID: 15063002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary structure of murine major histocompatibility complex alloantigens: amino acid sequence of the amino-terminal one hundred and seventy-three residues of the H-2Kb glycoprotein.
    Uehara H; Ewenstein BM; Martinko JM; Nathenson SG; Coligan JE; Kindt TJ
    Biochemistry; 1980 Jan; 19(2):306-15. PubMed ID: 6986168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunosuppressory and adhesive miniregion of the human major histocompatibility protein, human leukocyte antigen DQ.
    Szewczuk Z; Stefanowicz P; Wilczyński A; Siemion IZ; Cierniewski CS; Kralisz U; Wieczorek Z
    Biopolymers; 1996; 40(5):571-83. PubMed ID: 9062075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel structural features of the human histocompatibility molecules HLA-DQ as revealed by modeling based on the published structure of the related molecule HLA-DR.
    Paliakasis K; Routsias J; Petratos K; Ouzounis C; Kokkinidis M; Papadopoulos GK
    J Struct Biol; 1996; 117(2):145-63. PubMed ID: 8931340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acid sequence of bovine brain derived class 1 heparin-binding growth factor.
    Strydom DJ; Harper JW; Lobb RR
    Biochemistry; 1986 Mar; 25(5):945-51. PubMed ID: 2421762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid sequence of bovine angiogenin.
    Bond MD; Strydom DJ
    Biochemistry; 1989 Jul; 28(14):6110-3. PubMed ID: 2775757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detailed characterization of an anti-factor IX monoclonal antibody that neutralizes the prolonged ox brain prothrombin time of hemophilia B(M) by synthetic peptides.
    Takahashi I; Kojima T; Sano M; Watanabe T; Kamiya T; Saito H
    Peptides; 2000 May; 21(5):603-8. PubMed ID: 10876041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of acetylcholinesterase with the G4 domain of the laminin alpha1-chain.
    Johnson G; Swart C; Moore SW
    Biochem J; 2008 May; 411(3):507-14. PubMed ID: 18215127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules.
    Nepom BS; Nepom GT; Coleman M; Kwok WW
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7202-6. PubMed ID: 8692969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete amino acid sequence of copper-zinc superoxide dismutase from Drosophila melanogaster.
    Lee YM; Friedman DJ; Ayala FJ
    Arch Biochem Biophys; 1985 Sep; 241(2):577-89. PubMed ID: 3929689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human class 1 heparin-binding growth factor: structure and homology to bovine acidic brain fibroblast growth factor.
    Harper JW; Strydom DJ; Lobb RR
    Biochemistry; 1986 Jul; 25(14):4097-103. PubMed ID: 2427112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.